High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade During Ibrutinib Therapy in Patients with CLL.

CHIODIN, G., D. DUTTON, EA. MARTINO, S. DRENNAN, I. TRACY, Laura ONDRIŠOVÁ, I. HENDERSON, A. D´AVOLA, Ch. PITSILLIDOU, Marek MRÁZ, P. JOHNSON, A. DUNCOMBE, G. PACKHAM, A. STEELE, H. PARKER, S. BONFIGLIO, L. SCARFO, LA. SUTTON, P. GHIA, MJJ. ROSE-ZERILLI, J. STREFFORD, F. STEVENSON and F. FORCONI. High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade During Ibrutinib Therapy in Patients with CLL. In 61st ASH Annual Meeting and Exposition. Orlando, Florida, USA. 2019.

Basic information

Original name

High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade During Ibrutinib Therapy in Patients with CLL.

Authors

CHIODIN, G., D. DUTTON, EA. MARTINO, S. DRENNAN, I. TRACY, Laura ONDRIŠOVÁ, I. HENDERSON, A. D´AVOLA, Ch. PITSILLIDOU, Marek MRÁZ, P. JOHNSON, A. DUNCOMBE, G. PACKHAM, A. STEELE, H. PARKER, S. BONFIGLIO, L. SCARFO, LA. SUTTON, P. GHIA, MJJ. ROSE-ZERILLI, J. STREFFORD, F. STEVENSON and F. FORCONI

Edition

61st ASH Annual Meeting and Exposition. Orlando, Florida, USA, 2019

---

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology